With ICE using Medicaid data, hospitals and states are in a bind over warning immigrant patients
The Trump administration’s move to give deportation officials access to Medicaid data is putting hospitals and states in…
Fitbit Launches Luffu, AI-Powered Health Tracking for the Whole Family
If you’ve ever wanted a way to keep all of your family’s health records in place, Fitbit may…
Roadmap: Transforming Indian healthcare, one specialty at a time
India has taken significant strides in the past decade in delivering healthcare to its 1.4 billion people. Insurance…
Blood thinners are a leading cause of drug-related harm. Can the risk be lowered?
Larry Bordeaux, 65, has been on blood thinners since 2010, after he started developing deadly clots following an…
The DIY therapy: When mental health advice comes from artificial intelligence | India News
On a phone screen, symptoms line up neatly. Restlessness, fatigue, poor sleep, a lingering sense of worry, and…
Subscribe to The Australian | Newspaper home delivery, website, iPad, iPhone & Android apps
The Australian Digital 12 Month Plan costs $416 (min. cost) for the first 12 months, charged as $32…
ASX 200 healthcare stock sinks 9% on FDA update
Image source: Getty Images Neuren Pharmaceuticals Ltd (ASX: NEU) shares have returned from their trading halt and are…
Ahead of its earnings results, Macquarie reckons this healthcare company is severely undervalued
Image source: Getty Images The long-suffering shareholders in Ebos Group Ltd (ASX: EBO) might be very happy to…
2 Healthcare Dividend Stocks That are Just What the Doctor Ordered
AbbVie and Medtronic have a long history of raising their dividends and continue to have healthy free cash…
Private health insurers take aim at rising specialists fees
When Luan Lawrenson-Woods was diagnosed with invasive breast cancer in 2017 she had to become an expert in…
Cancer drugs among nearly 400 medicines at risk of shortage in UK
Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The…
Eli Lilly Soared by 39% in 2025, but Here’s Another Healthcare Stock to Buy in 2026
Key Points Eli Lilly has leading products in the GLP-1 space, with plans to bring pill versions of…